Unfortunately, women's reproductive health is an underdeveloped area within the healthcare industry. Despite a growing global infertility crisis, fertility therapies have remained largely unimproved since inception decades ago. To make matters worse, inclusion of women in clinical trials was not required until 1993. Therefore, many modern-day products are understudied in women resulting in lack of understanding and efficacy, and potentially leading to severe side effects.

Gameto is working to fill this gap in the industry with therapies that will not only improve the female reproductive journey, but improve lives.